Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell lines

Gallbladder carcinoma: Prognostic factors and therapeutic options

(2015) Thorsten Oliver Goetze   WORLD JOURNAL OF GASTROENTEROLOGY

Gallbladder Cancer in the 21st Century

(2015) Rani Kanthan et al.   Journal of Oncology

The Biological Function and Clinical Utilization of CD147 in Human Diseases: A Review of the Current Scientific Literature

(2014) Lijuan Xiong et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis

(2012) Anne M. Horgan et al.   JOURNAL OF CLINICAL ONCOLOGY

Neither Neoadjuvant nor Adjuvant Therapy Increases Survival After Biliary Tract Cancer Resection with Wide Negative Margins

(2012) Evan S. Glazer et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Gallbladder cancer: Can newer insights improve the outcome?

(2011) Usha Dutta   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Receptor Activator of NF- B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147

(2010) N. Rucci et al.   CANCER RESEARCH

CD147 and VEGF Expression in Advanced Renal Cell Carcinoma and Their Prognostic Value

(2009) Yu-Xiang Liang et al.   CANCER INVESTIGATION

Doxycycline inhibits the adhesion and migration of melanoma cells by inhibiting the expression and phosphorylation of focal adhesion kinase (FAK)

(2009) Tao Sun et al.   CANCER LETTERS

Epidemiology of biliary tract cancers: an update

(2008) G. Randi et al.   ANNALS OF ONCOLOGY

Prediction of prognosis in gallbladder carcinoma by CD147 and MMP-2 immunohistochemistry

(2008) Wei Wu et al.   MEDICAL ONCOLOGY

Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis

(2008) Y. Yang et al.   RHEUMATOLOGY